<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dicerna Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The Company is using its proprietary GalXC RNAi technology platform to build a broad pipeline in these therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $188,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas M. Fambrough, III, Ph.D.
    • FOUNDED
      2007
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Summit Therapeutics plc

    Summit Therapeutics plc

    Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibi...

    Summit Therapeutics is a leader in antibiotic i...

    Filing Type:    PU
    Alternaturals, Inc.

    Alternaturals, Inc.

    Alternaturals, Inc. manufactures and sells alternative healthcare products includi...

    Alternaturals, Inc. manufactures and sells alte...

    GENFIT S.A.

    GENFIT S.A.

    GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and de...

    GENFIT is a late-stage biopharmaceutical compan...

    Filing Type:    PU
    Achieve Life Sciences, Inc.

    Achieve Life Sciences, Inc.

    Achieve is a specialty pharmaceutical company committed to advancing cytisinicline...

    Achieve is a specialty pharmaceutical company c...

    Filing Type:    PU
    AzurRx BioPharma, Inc.

    AzurRx BioPharma, Inc.

    AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) f...

    AzurRx BioPharma is a development stage biophar...

    Filing Type:    PU
    Atreca, Inc.

    Atreca, Inc.

    Atreca is a biotechnology company developing novel therapeutics drawn from human i...

    Atreca is a biotechnology company developing no...

    Filing Type:    PU
    Madrigal Pharmaceuticals, Inc.

    Madrigal Pharmaceuticals, Inc.

    Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing no...

    Madrigal Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    CHF Solutions, Inc.

    CHF Solutions, Inc.

    CHF Solutions is focused on improving the quality of life for patients suffering f...

    CHF Solutions is focused on improving the quali...

    Filing Type:    PU
    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device compan...

    Cardiovascular Systems, Inc., based in St. Paul...

    Filing Type:    PU
    Kitov Pharma Ltd.

    Kitov Pharma Ltd.

    Kitov Pharma is an innovative biopharmaceutical drug development company. Leveragi...

    Kitov Pharma is an innovative biopharmaceutical...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.